Janssen Failed to Warn of Ketoacidosis Risk with Invokana Diabetes Drug, Suit Alleges
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is accused of failing to warn about the risk of ketoacidosis with its type 2 diabetes drug Invokana. Diabetic ketoacidosis is a serious condition caused by the build up of ketone bodies, leading to acidic blood levels. It can result in a diabetic coma and even death. … [Read more...]
Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
A Florida woman alleges, in a recent lawsuit brought against the makers of Invokana--Janssen Pharmaceuticals, and its parent company Johnson & Johnson (J&J)--, that the drug makers neglected to issue a proper warning about the connection between Invokana and ketoacidosis, a condition that occurs when too much acid builds up … [Read more...]
